美国启动医保谈判,礼来市值跌破7000亿

医药财经
19 Jan

美东时间1月17日,美国政府宣布,将诺和诺德的减肥药Wegovy和糖尿病药物Ozempic等15种高价药物列入2027年医保价格谈判计划。此举一出,迅速在产业和投资界引发了广泛关注。礼来制药的减肥药虽然不在清单之中,但该公司的股价也受此消息间接“躺枪”。消息公布后,诺和诺德股价下跌超5%,市值已经低于强生屈居第三;礼来制药股价下跌超4%,市值跌破7000亿美元大关。医保谈判引发市场震动根据美国媒体...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10